In brain diseases, the ST2 receptor is activated by the consequent production of IL-33, promoting the secretion of IL-13, which is associated with type 2 inflammation and is an ideal target for inhibiting the inflammatory response [112]. This evidence concerns the gene IL33 and brain disorder.